Nigel Greene

Nigel Greene currently leads the Computational Toxicology & Data Science group which is part of Imaging and Data Analytics at AstraZeneca and is interested in the application of artificial intelligence methods to understand of mechanisms of drug-induced toxicity and their translation to a clinical patient population. Previously, Dr Greene spent 14 years at Pfizer Inc. where he started in Drug Safety R&D and later transitioned to the Compound Safety Prediction group in Medicinal Chemistry. In his early career, Dr. Greene worked for Lhasa Ltd. where he pioneered computational toxicology, and for Tripos Inc.

Nigel's other activities outside of AstraZeneca have included being the Chair of the Board of Trustees for Lhasa Ltd. and he has served on multiple National Research Council committees sponsored by the US EPA, US FDA, and the NIH.

Dr. Greene received his B.Sc. and PhD from the University of Leeds in the UK.